Wipawee Juengsanguanpornsuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wipawee Juengsanguanpornsuk has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Waraporn Putalun
Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand
4 shared publications - Gorawit Yusakul
Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand
3 shared publications - Seiichi Sakamoto
Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashi-Ku, Japan
3 shared publications - Suppalak Phaisan
School of Biomolecular Science and Engineering Vidyasirimedhi Institute of Science and Technology (VISTEC) Wangchan Valley Rayong Thailand
2 shared publications - Attapon Sakdamas
School of Pharmacy, Walailak University, Nakhon Si Thammarat, Thailand
1 shared publication - Boonchoo Sritularak
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
1 shared publication
Latest Publications
- 30 November 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (1) , e70276
Lateal Flow Immunoassay for Sensitive and Rapid Detection of Methylisomiroestrol in Pueraria candollei Using Monoclonal Antibody
Methylisomiroestrol is a novel chromene compound with moderate estrogenic activity and an important biomarker for quality control in Pueraria candollei . The indirect competitive enzyme‐linked immunosorbent assay (icELISA) provides high sensitivity, complexity, time consumption, and difficulty for practical fields. This study aimed to develop a rapid qualitative detection for methylisomiroestrol in P. candollei using monoclonal antibodies as lateral flow immunoassay (LFIA). The LFIA was developed and evaluated for sensitivity, cross‐reactivity, and application to plant samples. Methylisomiroestrol (0.12–62.5 ng/mL) was used to determine the limit of detection (LOD). Cross‐reactivity was assessed with related compounds such as chromenes and isoflavonoids. The developed method was applied to detect methylisomiroestrol in P. candollei samples and compared to icELISA. The LFIA showed 31.25 ng/mL for the LOD of methylisomiroestrol within 15 min. Cross‐reactivity revealed interactions with related chromenes including isomiroestrol (8.89%), miroestrol (4.22%), and deoxymiroestrol (3.08%) and isoflavonoid compounds (< 0.6%). The application to P. candollei samples showed consistency results with the icELISA method that confirmed the qualitative detection of methylisomiroestrol in both root and stem materials. The developed LFIA provided a simple, quick, and easy‐to‐use method for the qualitative detection of methylisomiroestrol for quality control. However, further improvement toward semiquantitative analysis would increase the method's utility for comprehensive herbal medicine standardization.
- 30 November 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (1) , e70276
Lateal Flow Immunoassay for Sensitive and Rapid Detection of Methylisomiroestrol in Pueraria candollei Using Monoclonal Antibody
Methylisomiroestrol is a novel chromene compound with moderate estrogenic activity and an important biomarker for quality control in Pueraria candollei . The indirect competitive enzyme‐linked immunosorbent assay (icELISA) provides high sensitivity, complexity, time consumption, and difficulty for practical fields. This study aimed to develop a rapid qualitative detection for methylisomiroestrol in P. candollei using monoclonal antibodies as lateral flow immunoassay (LFIA). The LFIA was developed and evaluated for sensitivity, cross‐reactivity, and application to plant samples. Methylisomiroestrol (0.12–62.5 ng/mL) was used to determine the limit of detection (LOD). Cross‐reactivity was assessed with related compounds such as chromenes and isoflavonoids. The developed method was applied to detect methylisomiroestrol in P. candollei samples and compared to icELISA. The LFIA showed 31.25 ng/mL for the LOD of methylisomiroestrol within 15 min. Cross‐reactivity revealed interactions with related chromenes including isomiroestrol (8.89%), miroestrol (4.22%), and deoxymiroestrol (3.08%) and isoflavonoid compounds (< 0.6%). The application to P. candollei samples showed consistency results with the icELISA method that confirmed the qualitative detection of methylisomiroestrol in both root and stem materials. The developed LFIA provided a simple, quick, and easy‐to‐use method for the qualitative detection of methylisomiroestrol for quality control. However, further improvement toward semiquantitative analysis would increase the method's utility for comprehensive herbal medicine standardization.
- 30 May 2023
- Published by Wiley in Phytochemical Analysis
- Vol. 34 (6) , 632-640
Immunoaffinity separation of miroestrol and deoxymiroestrol from Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham using fragment antigen‐binding antibody produced via Escherichia coli
Introduction: Miroestrol and deoxymiroestrol are potent phytoestrogens and are oestrogen markers of Pueraria candollei var. mirifica. However, purifying these compounds is difficult because they only exist in trace amounts.Objectives: Active fragment antigen‐binding (Fab) antibodies were produced via Escherichia coli SHuffle® T7 and used to selectively separate these compounds.Materials and methods: Two immunoaffinity separation approaches were developed, namely the immunoaffinity column (IAC) and a cell‐based method. Group‐specific Fab antibodies against miroestrol and deoxymiroestrol (anti‐MD Fab) were used as biological binding reagents for selective separation.Results: The Fab‐based IAC effectively separated miroestrol and deoxymiroestrol (0.65 and 2.24 μg per 2 mL of resin, respectively) from P. mirifica root extract. When P. mirifica extract was added to E. coli cultures during Fab expression via a cell‐based method, the target compound accumulated in intracellular compartments and, thus, were separated from E. coli cells after the removal of other compounds. A yield of 1.07 μg of miroestrol per gram of cell pellet weight was obtained. Miroestrol and deoxymiroestrol were successfully purified from P. mirifica extract using anti‐MD Fab via the IAC and an intracellular cell‐based method.Conclusion: The proposed methods can simplify the miroestrol and deoxymiroestrol extraction process and provide a basis for applications utilising recombinant antibodies to separate target compounds.
- 30 May 2023
- Published by Wiley in Phytochemical Analysis
- Vol. 34 (6) , 632-640
Immunoaffinity separation of miroestrol and deoxymiroestrol from Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham using fragment antigen‐binding antibody produced via Escherichia coli
Introduction: Miroestrol and deoxymiroestrol are potent phytoestrogens and are oestrogen markers of Pueraria candollei var. mirifica. However, purifying these compounds is difficult because they only exist in trace amounts.Objectives: Active fragment antigen‐binding (Fab) antibodies were produced via Escherichia coli SHuffle® T7 and used to selectively separate these compounds.Materials and methods: Two immunoaffinity separation approaches were developed, namely the immunoaffinity column (IAC) and a cell‐based method. Group‐specific Fab antibodies against miroestrol and deoxymiroestrol (anti‐MD Fab) were used as biological binding reagents for selective separation.Results: The Fab‐based IAC effectively separated miroestrol and deoxymiroestrol (0.65 and 2.24 μg per 2 mL of resin, respectively) from P. mirifica root extract. When P. mirifica extract was added to E. coli cultures during Fab expression via a cell‐based method, the target compound accumulated in intracellular compartments and, thus, were separated from E. coli cells after the removal of other compounds. A yield of 1.07 μg of miroestrol per gram of cell pellet weight was obtained. Miroestrol and deoxymiroestrol were successfully purified from P. mirifica extract using anti‐MD Fab via the IAC and an intracellular cell‐based method.Conclusion: The proposed methods can simplify the miroestrol and deoxymiroestrol extraction process and provide a basis for applications utilising recombinant antibodies to separate target compounds.
- Open Access
- 27 September 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (51) , 32067-32076
Transformation of Pueraria candollei var. mirifica phytoestrogens using immobilized and free β-glucosidase, a technique for enhancing estrogenic activity
Transformation of Pueraria candollei var. mirifica phytoestrogens by β-glucosidase increases estrogenic activity.
- 27 September 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (51) , 32067-32076
Open AccessTransformation of Pueraria candollei var. mirifica phytoestrogens using immobilized and free β-glucosidase, a technique for enhancing estrogenic activity
Transformation of Pueraria candollei var. mirifica phytoestrogens by β-glucosidase increases estrogenic activity.
- 20 February 2020
- Published by Taylor & Francis in Natural Product Research
- Vol. 35 (21) , 4110-4114
(+)-7-O-Methylisomiroestrol, a new chromene phytoestrogen from the Pueraria candollei var. mirifica root
(+)-7-O-Methylisomiroestrol (MeI), a novel chromene, was discovered as a phytoestrogen in the Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham (PM) root having been used as an active agent against oestrogen depletion disorders. The identification of PM phytochemicals is crucial for the development of standardised botanical drugs of PM. MeI was purified from the root cortex of PM, and its structure was elucidated using NMR and mass spectrometry. The content of MeI in the root bark of the PM root was 2.1–6.5 × 10−3% (w/w). The oestrogenic potency of MeI was stronger than that of isomiroestrol but less than that of deoxymiroestrol and miroestrol. Therefore, MeI is a new oestrogenic biomarker for the effective chemical standardisation of the PM extract for health product development.
- 20 February 2020
- Published by Taylor & Francis in Natural Product Research
- Vol. 35 (21) , 4110-4114
(+)-7-O-Methylisomiroestrol, a new chromene phytoestrogen from the Pueraria candollei var. mirifica root
(+)-7-O-Methylisomiroestrol (MeI), a novel chromene, was discovered as a phytoestrogen in the Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham (PM) root having been used as an active agent against oestrogen depletion disorders. The identification of PM phytochemicals is crucial for the development of standardised botanical drugs of PM. MeI was purified from the root cortex of PM, and its structure was elucidated using NMR and mass spectrometry. The content of MeI in the root bark of the PM root was 2.1–6.5 × 10−3% (w/w). The oestrogenic potency of MeI was stronger than that of isomiroestrol but less than that of deoxymiroestrol and miroestrol. Therefore, MeI is a new oestrogenic biomarker for the effective chemical standardisation of the PM extract for health product development.